-
Biogen Inc. (BIIB $151.05)
-
AbbVie Inc. (ABBV $231.28)
-
Eli Lilly and Company (LLY $848.03)
-
Savaria Corporation (SIS $21.43)
-
Health Care Select Sector SPDR (XLV $144.55)
Q: I just sold off my Biogen holding and am looking for a replacement within the healthcare sector. I held Biogen for over 3 years and exited with a nice return, but I have to say that I did not enjoy the wild ride and price swings as it seemed to trade solely on its new Alzheimer’s drug advancements and setbacks. So now I am looking to replace it with something a little more stable but still with the expectation of slow and steady growth. What would be your top 1 or 2 picks be today for both the US and Canada that might fit. I already own Savaria and XLV so something besides these.